https://pixabay.com/en/notebook-work-girl-computer-woman-2386034/

PointR Data Merges into Mateon Therapeutics — Company Will Focus on Using Data Analysis and AI to Develop New Treatments

• Post author:Scott Carlson
• Post published:August 30, 2019
• Post category:Pancreatic Cancer/Rare Disease

According to a press release from Mateon Therapeutics, Mateon's recent merger agreement with PointR Data establishes plans to combine the use of artificial intelligence and data collection for the development…

Continue Reading PointR Data Merges into Mateon Therapeutics — Company Will Focus on Using Data Analysis and AI to Develop New Treatments

Pexels / Pixabay

Amicus Therapeutics Continue to Develop Investigative Treatments for Fabry, Pompe, and Batten Diseases

• Post author:Scott Carlson
• Post published:August 30, 2019
• Post category:Batten Disease/Fabry Disease/Pompe Disease

According to a publication from Fabry Disease News, Amicus Therapeutics has as many as 14 investigational drugs currently in development for the treatment of rare diseases including Fabry, Pompe, and…

Continue Reading Amicus Therapeutics Continue to Develop Investigative Treatments for Fabry, Pompe, and Batten Diseases

41330 / Pixabay

New Progress is Being Made Against Often Overlooked Tropical Diseases

• Post author:James Moore
• Post published:August 30, 2019
• Post category:Rare Disease

According to a story from New Statesman, the last month has seen a number of new drugs introduced that could have a significant impact on several dangerous tropical diseases, such…

Continue Reading New Progress is Being Made Against Often Overlooked Tropical Diseases

stevepb / Pixabay

First Human Trial Completed for Experimental Scleroderma and Multiple Sclerosis Drug

• Post author:James Moore
• Post published:August 30, 2019
• Post category:Multiple Sclerosis/Systemic Scleroderma/Systemic Sclerosis

According to a story from Financial Buzz, the drug developer Emerald Health Pharmaceuticals, Inc., recently announced that the company had completed a phase 1 clinical trial for its experimental drug…

Continue Reading First Human Trial Completed for Experimental Scleroderma and Multiple Sclerosis Drug

jarmoluk / Pixabay

New Study Suggests as Many as Half of Systemic Sclerosis Patients Affected by Sarcopenia

• Post author:Scott Carlson
• Post published:August 30, 2019
• Post category:Systemic Sclerosis

According to a publication from Scleroderma News, a recent study published in Rheumatology International suggests that the majority of systemic sclerosis patients experience sarcopenia as a result of their condition. Perhaps…

Continue Reading New Study Suggests as Many as Half of Systemic Sclerosis Patients Affected by Sarcopenia

CTD Holdings Gives Presentation on Investigatory Niemann-Pick Type C Drug at Family Support and Medical Conference

• Post author:Scott Carlson
• Post published:August 30, 2019
• Post category:Niemann-Pick Type C Disease

According to a press release from CTD Holdings, a biotechnology company based in Gainesville, Florida, the Company recently presented data collected from their investigatory Niemann-Pick Disease treatment, Trappsol Cyclo, to…

Continue Reading CTD Holdings Gives Presentation on Investigatory Niemann-Pick Type C Drug at Family Support and Medical Conference

Former NFL Star Tim Green has ALS but No Regrets About His Career

• Post author:Rose Duesterwald
• Post published:August 30, 2019
• Post category:Amyotrophic Lateral Sclerosis

  In 1996, Tim Green made the comment that you cannot go through an NFL season without doing serious damage to your body. In a recent 60 Minutes interview with Steve…

Continue Reading Former NFL Star Tim Green has ALS but No Regrets About His Career

source: pixabay.com

Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation

• Post author:James Moore
• Post published:August 30, 2019
• Post category:Myelodysplastic syndromes/Pancreatic Cancer/Rare Disease

According to a story from BioSpace, the biopharmaceutical company CrystalGenomics, Inc. recently announced that the US Food and Drug Administration (FDA) has granted the company's investigational drug candidate CG-745 Orphan…

Continue Reading Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation